Fourth-year students at Geisinger College of Health Sciences’ School of Medicine celebrated Match Day on Friday at the Scranton Cultural Center, where they learned where they will continue their ...

Detailed price information for 4D Molecular Therapeutics Inc (FDMT-Q) from The Globe and Mail including charting and trades.

The FDA recently approved the first treatment in nearly 30 years for acute stroke, and the agency also approved a novel drug ...

Enhanced extended bolus up to 8 hours with Control-IQ+ turned on ... Center for Diabetes and professor of pediatrics at the ...

Treatment by Tenderizer” claimed that meat tenderizer could soothe an aching back. That was the theory, and, as ...

Care announced publication by The New England Journal of Medicine of results from the company’s pivotal trial of ...

Tandem Diabetes Care announced today that it launched its next-generation Control-IQ+ automated insulin delivery algorithm in ...

The FDA approved a one-time, five-minute IV bolus infusion of tenecteplase for ... Ophthalmology and Internal Medicine at Genentech, told Healio. “This milestone strengthens our commitment ...

Tandem Diabetes Care (Nasdaq:TNDM) today announced positive data supporting its automated insulin delivery technology for ...

The incident occurred recently at Lifecare Hospital in Musaffah, where Dr Aboobacker Sidhique, a Specialist in Emergency ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced publication by The New England Journal of Medicine (NEJM ... at ATTD Additional ...